Liver cancer cases expected to nearly double by 2050, driven mainly by obesity, alcohol, and viral hepatitis, but over 60% are preventable through public health measures.
Carlyle Group appoints three co-presidents to lead its transformation and drive growth across various business segments.
Bavarian Nordic, a vaccine maker, agrees to a $3 billion buyout by a consortium led by Nordic Capital and Permira.
Liver cancer cases expected to nearly double by 2050, driven mainly by obesity, alcohol, and viral hepatitis, but over 60% are preventable through public health measures.
Carlyle Group appoints three co-presidents to lead its transformation and drive growth across various business segments.
Bavarian Nordic, a vaccine maker, agrees to a $3 billion buyout by a consortium led by Nordic Capital and Permira.